首页 > 科室新闻 >
预约就诊
021-5169 9696
我科于肿瘤类著名期刊Cancer Letters连续发表两篇论著!

Cancer Letters是肿瘤类著名期刊,目前影响因子为5.992。
进入2016年后,我科在Cancer Letters连续发表两篇论著,通讯作者分别为陈岳祥教授和张新教授,这是我科在肝癌研究领域取得的新进展。


Zhang PP, Wang PQ, Qiao CP, Zhang Q, Zhang JP, Chen F, Zhang X, Xie WF, Yuan ZL, Li ZS, Chen YX*. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine. Cancer Lett. 2016, 376(1):95-103.
Liu J, Chen S, Wang W, Ning BF, Chen F, Shen W, Ding J, Chen W, Xie WF*, Zhang X*. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Cancer Lett. 2016, 379(1):49-59.